Key Points Plasma levels of Reg3α were significantly increased in patients with GI-cGVHD compared with those without GI-cGVHD in 2 independent cohorts. Reg3α is a prognostic biomarker that identifies the… Click to show full abstract
Key Points Plasma levels of Reg3α were significantly increased in patients with GI-cGVHD compared with those without GI-cGVHD in 2 independent cohorts. Reg3α is a prognostic biomarker that identifies the likelihood of NRM in patients with GI-cGVHD.
               
Click one of the above tabs to view related content.